Search
News
Important Only
Vanda Pharmaceuticals Announces Initiation Of The Thetis Study, A Clinical Trial Of Nereus™ For The Prevention Of Vomiting Induced By Glp-1 Receptor Agonists
April 8 (Reuters) - Vanda Pharmaceuticals Inc VNDA.O:VANDA PHARMACEUTICALS ANNOUNCES INITIATION OF THE THETIS STUDY, A CLINICAL TRIAL OF NEREUS™ FOR THE PREVENTION OF VOMITING INDUCED BY GLP-1 RECEPTOR AGONISTSVANDA PHARMACEUTICALS INC - TOPLINE RESULTS FROM THETIS STUDY EXPECTED BY Q4 2026VANDA PHA...Reuters
4 minutes ago
Aehr Test Systems Entered Into Equity Distribution Agreement With William Blair & Company & Craig-Hallum Capital Group
April 8 (Reuters) - Aehr Test Systems AEHR.O:AEHR TEST SYSTEMS: ENTERED INTO EQUITY DISTRIBUTION AGREEMENT WITH WILLIAM BLAIR & COMPANY & CRAIG-HALLUM CAPITAL GROUPAEHR TEST SYSTEMS: MAY AND SELL UP TO $60 MILLION COMMON STOCKSource text: [ID:n0001654954-26-003353]Reuters
4 minutes ago
Leifras Co., Ltd. Reports Fiscal Year 2025 Financial Results
April 8 (Reuters) - Leifras Co Ltd LFS.O:LEIFRAS CO., LTD. REPORTS FISCAL YEAR 2025 FINANCIAL RESULTSLEIFRAS CO LTD: REVENUE IS EXPECTED TO BE BETWEEN $82.9 MILLION AND $95.7 MILLION FOR FISCAL YEAR ENDING DEC 31, 2026LEIFRAS CO LTD - SEES FY2026 REVENUE $82.9 MILLION-$95.7 MILLIONReuters
4 minutes ago
Phio Pharmaceuticals Corp - Enters At The Market Offering Agreement With H.C. Wainwright On April 8, 2026
April 8 (Reuters) - Phio Pharmaceuticals Corp PHIO.O:PHIO PHARMACEUTICALS CORP - ENTERS AT THE MARKET OFFERING AGREEMENT WITH H.C. WAINWRIGHT ON APRIL 8, 2026 - SEC FILINGPHIO PHARMACEUTICALS CORP - TO OFFER UP TO $6.36 MILLION OF SHARES UNDER SALES AGREEMENT - SEC FILINGSource text: [ID:n0001437749...Reuters
4 minutes ago
Costco Wholesale Corporation Reports March Sales Results
April 8 (Reuters) - Costco Wholesale Corp COST.O:COSTCO WHOLESALE CORPORATION REPORTS MARCH SALES RESULTSCOSTCO WHOLESALE CORP - REPORTS MARCH NET SALES OF $28.41 BILLION, UP 11.3% FOR FIVE WEEKS ENDED APRIL 5, 2026COSTCO WHOLESALE CORP - COMPARABLE SALES FOR FIVE WEEKS ENDED APRIL 5 TOTAL CO 9.4%CO...Reuters
5 minutes ago
Cosette Pharmaceuticals Expands Branded Portfolio Through Acquisition Of Sympazan® And Additional Products From Assertio
April 8 (Reuters) - Assertio Holdings Inc ASRT.O:COSETTE PHARMACEUTICALS EXPANDS BRANDED PORTFOLIO THROUGH ACQUISITION OF SYMPAZAN® AND ADDITIONAL PRODUCTS FROM ASSERTIOReuters
5 minutes ago
Abony Acquisition Corp. I Announces The Separate Trading Of Its Class A Ordinary Shares And Warrants, Commencing On Or About April 13, 2026
April 8 (Reuters) - Abony Acquisition Corp I AACOU.O:ABONY ACQUISITION CORP. I ANNOUNCES THE SEPARATE TRADING OF ITS CLASS A ORDINARY SHARES AND WARRANTS, COMMENCING ON OR ABOUT APRIL 13, 2026Reuters
5 minutes ago
Everspin Technologies Expands On-Shore Mram Manufacturing Capacity
April 8 (Reuters) - Everspin Technologies Inc MRAM.O:EVERSPIN TECHNOLOGIES EXPANDS ON-SHORE MRAM MANUFACTURING CAPACITYEVERSPIN TECHNOLOGIES INC - ANNOUNCES STRATEGIC MANUFACTURING AGREEMENT WITH MICROCHIP TECHNOLOGYEVERSPIN TECHNOLOGIES INC - ENTERS INITIAL 10-YEAR AGREEMENT WITH MICROCHIP TO AUGME...Reuters
5 minutes ago
Averin Capital Acquisition Corp. Announces The Separate Trading Of Its Class A Ordinary Shares And Warrants, Commencing April 10, 2026
April 8 (Reuters) - Averin Capital Acquisition Corp ACAAU.O:AVERIN CAPITAL ACQUISITION CORP. ANNOUNCES THE SEPARATE TRADING OF ITS CLASS A ORDINARY SHARES AND WARRANTS, COMMENCING APRIL 10, 2026Reuters
6 minutes ago
Avalyn Pharma Inc Announces Initial Public Offering Of Common Stock
April 8 (Reuters) - AVALYN PHARMA INC - ANNOUNCES INITIAL PUBLIC OFFERING OF COMMON STOCK - SEC FILINGAVALYN PHARMA INC - APPLIES TO LIST COMMON STOCK ON NASDAQ UNDER SYMBOL AVLN - SEC FILINGAVALYN PHARMA INC: MORGAN STANLEY, JEFFERIES, EVERCORE ISI, GUGGENHEIM SECURITIES ARE UNDERWRITERS TO IPOSour...Reuters
6 minutes ago
REFILE-France's Macron tells Iran, US leaders that ceasefire decision was best choice
April 8 (Reuters) - French President Emmanuel Macron said on Wednesday that he spoke with both Iranian President Masoud Pezeshkian, as well as with U.S. President Donald Trump, and told them their decision to accept a ceasefire was the best possible one. "I expressed my hope that the ceasefire w...Reuters
6 minutes ago
Trump administration cannot nix legal status of 5,000 Ethiopians, US judge rules
By Nate RaymondBOSTON, April 8 (Reuters) - A federal judge on Wednesday halted a move by U.S. President Donald Trump's administration to end legal protections granted to over 5,000 Ethiopians that have allowed them to live and work in the United States.The ruling by U.S. District Judge Brian Mur...Reuters
8 minutes ago
'Ketamine Queen' sentenced to 15 years in death of 'Friends' star Matthew Perry
Jasveen Sangha pleaded guilty to five felony drug countsTV star Perry died at his Los Angeles home in 2023Sangha had supplied dose of ketamine that killed actorShe expresses remorse for her role in Perry's deathBy Lisa Richwine and Steve Gorman LOS ANGELES, April 8 (Reuters) - A drug dealer d...Reuters
10 minutes ago
Iraq tells France it arrested perpetrators behind drone attack that killed French soldier
CAIRO, April 8 (Reuters) - Iraq's Prime Minister Mohammed Shia al-Sudani told French President Emmanuel Macron that authorities arrested perpetrators behind a drone attack in March that killed a French soldier in Erbil, according to a statement by the Iraqi prime minister's office.One French...Reuters
18 minutes ago
Tuhura Biosciences Inc Enters At The Market Offering Agreement With H.C. Wainwright & Co.
April 8 (Reuters) - TuHURA Biosciences Inc HURA.O:TUHURA BIOSCIENCES INC - ENTERS AT THE MARKET OFFERING AGREEMENT WITH H.C. WAINWRIGHT & CO. - SEC FILINGTUHURA BIOSCIENCES INC - MAY OFFER COMMON STOCK UP TO $50 MILLION AGGREGATE - SEC FILINGSource text: [ID:n0001193125-26-147748]Reuters
36 minutes ago
FDA Removes Partial Clinical Hold On Macrogenics’ Linnet Study
April 8 (Reuters) - MacroGenics Inc MGNX.O:FDA REMOVES PARTIAL CLINICAL HOLD ON MACROGENICS’ LINNET STUDYMACROGENICS INC - NEW PARTICIPANTS TO BE ENROLLED UNDER REVISED PROTOCOL WITH ADDITIONAL RISK-MITIGATION MEASURESMACROGENICS INC: WE REMAIN ON TRACK TO PROVIDE A MID-YEAR CLINICAL UPDATE ON PROGR...Reuters
36 minutes ago
Catalyst Bancorp, Inc. Announces Agreement To Acquire Lakeside Bancshares, Inc.
April 8 (Reuters) - Catalyst Bancorp Inc CLST.O:CATALYST BANCORP, INC. ANNOUNCES AGREEMENT TO ACQUIRE LAKESIDE BANCSHARES, INC.CATALYST BANCORP INC: CATALYST WILL ACQUIRE LAKESIDE IN AN ALL-CASH TRANSACTIONCATALYST BANCORP INC: LAKESIDE'S SHAREHOLDERS (OTHER THAN DISSENTING SHARES) TO RECEIVE $1...Reuters
37 minutes ago
